Companies /Healthcare

Mustang Bio Inc

NASDAQ: MBIO Biotechnology
$0.53
▼ $0.01 (−2.42%) today
Markets closed · 10:48pm ET
Today · % change

Fundamentals

Market Cap
$4.1M
Revenue (TTM)
$-50,000
EPS (TTM)
$-0.42
52-Week Range
$1 – $2
Street Target
$10.00

About Mustang Bio

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company is headquartered in Worcester, Massachusetts.

MBIO Coverage